VOCABRIA

This brand name is authorized in United States. It is also authorized in Austria, Canada, Croatia, Estonia, Finland, France, Ireland, Israel, Italy, Japan, Lithuania, Poland, Romania, Spain.

Active ingredients

The drug VOCABRIA contains one active pharmaceutical ingredient (API):

1	Cabotegravir UNII 3L12PT535M - CABOTEGRAVIR SODIUM
	Cabotegravir inhibits HIV integrase by binding to the integrase active site and blocking the strand transfer step of retroviral deoxyribonucleic acid (DNA) integration which is essential for the HIV replication cycle.
	Read more about Cabotegravir

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
VOCABRIA Film-coated tablet	MPI, EU: SmPC	European Medicines Agency (EU)
VOCABRIA Film-coated tablet	MPI, US: SPL/PLR	FDA, National Drug Code (US)
VOCABRIA Prolonged-release suspension for injection	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J05AJ04	Cabotegravir	J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AJ Integrase inhibitors
Discover more medicines within J05AJ04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02497204
EE	Ravimiamet	1835940, 1835951, 1835962
ES	Centro de información online de medicamentos de la AEMPS	1201481001, 1201481003
FI	Lääkealan turvallisuus- ja kehittämiskeskus	104241, 528379
FR	Base de données publique des médicaments	60543082, 67129301
IL	מִשְׂרַד הַבְּרִיאוּת	9045, 9046
IT	Agenzia del Farmaco	049281013, 049281025, 049281037
JP	医薬品医療機器総合機構	6250050F1024, 6250408A1028, 6250408A2024
LT	Valstybinė vaistų kontrolės tarnyba	1091692, 1091693, 1091694
PL	Rejestru Produktów Leczniczych	100441698, 100441706, 100441712
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W67282001, W67283001, W67284001
US	FDA, National Drug Code	49702-248